Fischer Medical Ventures Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fischer Medical Ventures Limited has filed its financial results with NSE for the period ended December 31, 2025, covering Q3 FY26 and the nine-month period. The headline announcement confirms only the submission of results and does not include detailed revenue, profit, or margin figures in this notice. Investors need to refer to the full results document to assess actual business performance for the quarter and year-to-date period. No commentary on auditor opinion, exceptional items, or restatements is provided in this filing notice.
This is a routine quarterly compliance filing and is unlikely to move the stock on its own. Shareholders should review the detailed financial results to gauge revenue growth, profitability, and margin trends before drawing conclusions about the company's performance.